Xoft raises $25M for targeted cancer treatment
Xoft, a Sunnyvale, Calif. company with an X-ray radiation treatment used for breast cancer and endometrial cancer, has raised a fifth round totaling $25 million, according to VentureWire.
The treatment uses targeting technology and tools to pinpoint the area being irradiated, limiting the damage done to the patient and allowing technicians to remain in the room.
New investor Chicago Growth Partners provided a majority of the funding, and was joined by previous investors including Easton Capital, Cutlass… Continue Reading
CardioKinetix raises $14.5M for catheter-based heart treatment
CardioKinetix, a Redwood City, Calif. life sciences startup working on a heart-failure treatment that could potentially help over a million patients, has raised a third round of funding, according to VentureWire.
The company’s procedure uses a catheter to strengthen parts of the heart, and protect areas damaged following heart attacks. The device is designed to be an alternative to a risky surgery typically only used in high-risk patients.
Previous investors Cutlass Capital, JPMorgan Partners and U.S. Venture… Continue Reading
Xoft raises $33.2M for breast cancer treatment
Xoft, a Fremont Ca. developer of a treatment to reduce the recurrence of breast cancer, said it has raised $33.2 million in a fourth round of financing, and plans to treat its first patients.
See statement here.
The company says its Axxent Electronic Brachytherapy System “uses a miniaturized X-ray source that can deliver localized and targeted radiation treatment,” and can be used in pretty much any environment, including unshielded environments.
The company has now raised a total of… Continue Reading